Topical Oxygen, ROS Dressings and Haemoglobin Sprays: Why the Evidence Is Not Interchangeable

Quick answer: Topical oxygen therapy, reactive-oxygen-species dressings and topical haemoglobin sprays are different wound-care technologies. They may all be discussed using oxygen-related language, but they use different materials or mechanisms. Evidence from one category, product or wound population cannot automatically be used to support another.

Words such as “oxygen”, “reactive oxygen” and “oxygen transport” can make several technologies sound interchangeable. They are not. Keeping them separate is essential for accurate patient education and responsible product claims.

1. Topical oxygen therapy

Topical oxygen therapy is a broad category intended to increase oxygen availability at or around the wound surface. Devices can differ in how oxygen is generated or delivered, how long it is applied and whether treatment is continuous or intermittent.

A 2026 systematic review indexed as PMID 42192209 pooled three randomized trials involving 325 participants with diabetic foot ulcers. The pooled result favoured topical oxygen used alongside standard care for complete closure at 12 weeks. The evidence base was still small, uncertainty remained and the review did not prove that every oxygen device or brand has the same result.

2. Reactive-oxygen-species dressings

Reactive oxygen species, often abbreviated to ROS, are chemically reactive oxygen-containing molecules. A dressing designed to generate or deliver ROS uses a different concept from a device that supplies molecular oxygen to the wound surface.

The cited ROS evidence was a randomized, controlled, parallel-arm, double-blind trial of 81 adults with colonized chronic wounds, allocated 2:1 to one oxygen-enriched oleic matrix dressing or one antimicrobial silver dressing. It does not establish effects for infected diabetic foot ulcers, another ROS dressing, a topical oxygen device or a haemoglobin spray.

3. Topical haemoglobin sprays

Terminology varies across publications. Some papers describe topical haemoglobin sprays as topical oxygen therapy, but their oxygen-carrier mechanism differs from systems that deliver oxygen gas. Evidence from a pooled review cannot be transferred unless the exact intervention was included.

Published evidence includes different study designs, including case reports. A case report can describe one patient’s clinical course but cannot establish typical effectiveness. Product claims should not be built by combining mechanistic theory, one case and unrelated category-level trials.

Why evidence transfer is unsafe

A clinical study is defined by several linked details:

  • the exact device or product;
  • the mechanism and treatment protocol;
  • the wound population and infection status;
  • the comparator and accompanying standard care;
  • the outcome and follow-up period;
  • the study design and risk of bias.

If any of these change, the claim may no longer be supported. A systematic review of topical oxygen devices does not automatically validate a haemoglobin spray. A trial of an ROS dressing does not establish that another oxygen-related product has the same effect.

Mechanism is not the same as clinical benefit

Oxygen is involved in several stages of tissue repair, and chronic wounds can involve local hypoxia. This biological rationale explains why researchers investigate oxygen-related approaches.

A plausible mechanism is the beginning of a research question, not the end. Clinical benefit must be demonstrated in patients using an appropriate comparator and meaningful outcomes. Safety, usability, cost and the wider care plan also matter.

Standard care remains central

No oxygen-related technology replaces the need to assess and address the causes of delayed healing. Depending on the wound, this may include pressure offloading, vascular assessment, infection management, debridement, moisture balance, diabetes care, nutrition and follow-up.

People with diabetic foot ulcers or other chronic wounds should not select or substitute a device from online descriptions alone. A wound professional should assess whether an adjunct is appropriate and how progress will be reviewed.

Five questions for any oxygen-related claim

  1. What exact technology and product were studied?
  2. Was the evidence a case report, trial or systematic review?
  3. Which wound population was included?
  4. Was the therapy used alongside standard care?
  5. Does the claim match the measured outcome?

Go to the nearest emergency department now for fever or chills with a worsening foot wound, confusion or marked weakness, rapidly spreading redness or swelling, pus with rapid deterioration, black or blue tissue, a suddenly cold or pale foot, or severe new pain at rest. Call 995 for a life-threatening emergency in Singapore. Seek same-day medical assessment for a new ulcer, increasing drainage or odour, new warmth or redness, or a wound becoming larger or deeper. Do not be reassured by little pain or no fever; neuropathy and poor circulation can blunt warning signs.

This article provides general education and does not replace individual assessment by a wound clinician, podiatrist or doctor.

Frequently asked questions

Is a haemoglobin spray the same as topical oxygen therapy?

Terminology varies. Some publications call haemoglobin sprays a form of topical oxygen therapy, but their oxygen-carrier mechanism differs from devices that deliver oxygen gas. Evidence must follow the exact intervention studied.

Are ROS dressings simply another topical oxygen device?

No. Reactive-oxygen-species dressings use a different material and mechanism. The exact product evidence must be reviewed separately.

Can one systematic review support every oxygen-related product?

No. A review’s result applies to the interventions, populations, comparators and outcomes included in that review.

Does a plausible oxygen mechanism prove faster healing?

No. Mechanistic plausibility supports research but does not establish a patient outcome or superiority.

Can an oxygen-related therapy replace standard wound care?

No. It is considered an adjunct. The wound’s cause, pressure, circulation, infection and wider health still require assessment.

References

返回博客